Frequency of Driver Genes (EGFR, KRAS, BRAF, ALK, RET and ROS1) Alterations in Brazilian Patients with Lung Adenocarcinoma

被引：2
|
作者：
Campanha Novaes, L. [1 ]
Cavagna, R. [1 ]
De Paula, F. [2 ]
De Marchi, P. [3 ]
Zanon Da Silva, M. [2 ]
Evangelista, A. [1 ]
Sussuchi Da Silva, L. [1 ]
Albino Da Silva, E. [4 ]
Leal, L. [1 ]
Reis, R. [1 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Barretos Canc Hosp, Dept Mol Diag, Barretos, Brazil
[3] Barretos Canc Hosp, Clin Oncol, Barretos, Brazil
[4] Barretos Canc Hosp, Pathol, Barretos, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
driver genes; Brazilian patients; lung adenocarcinoma;
D O I：
10.1016/j.jtho.2019.08.1454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-07
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [41] EGFR, KRAS and ALK Gene Alterations in Lung Cancer Patients in Croatia
    Jakopovic, Marko
    Brcic, Luka
    Misic, Marija
    Bubanovic, Gordana
    Seiwerth, Fran
    Drpa, Gordana
    Cucevic, Branka
    Roglic, Mihovil
    Plestina, Sanja
    Kukulj, Suazana
    Smojver-Jezek, Silvana
    Seiwerth, Sven
    Samarzija, Miroslav
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S517 - S517
  • [42] Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
    Rogers, Toni-Maree
    Arnau, Gisela Mir
    Ryland, Georgina L.
    Huang, Stephen
    Lira, Maruja E.
    Emmanuel, Yvette
    Perez, Omar D.
    Irwin, Darryl
    Fellowes, Andrew P.
    Wong, Stephen Q.
    Fox, Stephen B.
    SCIENTIFIC REPORTS, 2017, 7
  • [43] Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
    Kohno, Takashi
    Nakaoku, Takashi
    Tsuta, Koji
    Tsuchihara, Katsuya
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Goto, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 156 - 164
  • [44] Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
    Toni-Maree Rogers
    Gisela Mir Arnau
    Georgina L. Ryland
    Stephen Huang
    Maruja E. Lira
    Yvette Emmanuel
    Omar D. Perez
    Darryl Irwin
    Andrew P. Fellowes
    Stephen Q. Wong
    Stephen B. Fox
    Scientific Reports, 7
  • [45] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
    Wu, Shafei
    Wang, Jinghui
    Zhou, Lijuan
    Su, Dan
    Liu, Yuanyuan
    Liang, Xiaolong
    Zhang, Shucai
    Zeng, Xuan
    THORACIC CANCER, 2015, 6 (04) : 413 - 420
  • [46] ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey
    Diniz, Gulden
    Komurcuoglu, Berna
    Ozyilmaz, Berk
    Ozguzer, Alp
    Yucel, Nur
    Kirbiyik, Ozgur
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (02) : 305 - 310
  • [47] Classic driver oncogenemutations in EGFR, ALK, ROS1 and PD-L1 expression in chemonaive lung adenocarcinoma specimens: clinico-pathological correlations
    Lunardi, F.
    Pezzuto, F.
    Fortarezza, F.
    Vuljan, S.
    Comacchio, G.
    Pasello, G.
    Rea, F.
    Calabrese, F.
    VIRCHOWS ARCHIV, 2019, 475 : S141 - S141
  • [48] Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Arrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S494 - S494
  • [49] Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    CANCER BIOLOGY & THERAPY, 2017, 18 (11) : 883 - 887
  • [50] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
    Cha, Yoon Jin
    Lee, Jae Seok
    Kim, Hye Ryun
    Lim, Sun Min
    Cho, Byoung Chul
    Lee, Chang Young
    Shim, Hyo Sup
    PLOS ONE, 2014, 9 (07):
12345